Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual Oncology Innovation Forum
-
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis
-
WalkMe Ltd. Announces First Quarter 2024 Financial Results
-
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024
-
LSL Pharma Group Announces Listing of Convertible Redeemable Debentures on the TSXV
-
Will AI Make Leaders Obsolete? AIIR Teams Up with Microsoft and Wharton to Consider the Implications
-
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
-
Akoustis Completes Rollout of its XBAW® Design Updates
-
Wesdome Appoints Kevin Lonergan as Senior Vice President, Technical Services
-
Invivyd Elects Two New Independent Members to its Board of Directors
-
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
-
Erie County to Deploy Microgrid at Rath Building with e2Companies R3Di® System
-
OTC Markets Group Welcomes Warpaint London PLC to OTCQX
-
Nokia successfully completes acquisition of Fenix Group, accelerating U.S. strategy
-
Gate.io Celebrates 11th Anniversary with Prize Activities and Vision for the Future
-
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease
-
TransUnion to Present at Upcoming Investor Conferences in New York and Chicago
-
Lands' End Announces First Quarter 2024 Earnings Conference Call
-
Lands' End Announces First Quarter 2024 Earnings Conference Call
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
PDD Holdings Announces First Quarter 2024 Unaudited Financial Results
-
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
-
Wallbridge Drilling at Fenelon Intersects Near Surface High-Grade Gold Mineralization
-
Photronics Reports Second Quarter Fiscal 2024 Results
-
Parsons Selected For LAWA’s Capital Improvement Program MATOC
-
Form 8.3 - Mattioli Woods
-
Formula Systems Reports First Quarter 2024 Financial Results
-
Form 8.3 - Lok’n Store Group PLC
-
Form 8.3 - Keywords Studios Plc
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
HSBC - DEALINGS DISCLOSURE - XP Power Limited
-
Form 8.3 - Alpha Financial Markets Consulting Plc
-
Scatec ASA: Mandatory notification of trade by primary insider
-
Fingrid to collect grid service fees from July until December
-
CorVel Announces Revenues and Earnings
-
Xinyuan Real Estate Co., Ltd. Releases 2023 Annual Report, Achieving Positive Net Profit Attributable to Shareholders
-
Wizz Air and Striim partnership will streamline mission-critical operations with real-time data pipelines
-
Hooker Furnishings to Host First Quarter Earnings Call June 6th
-
Dycom Industries, Inc. Announces Fiscal 2025 First Quarter Results
-
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
-
ProcessMaker Wins Top Award as 2024 Best Generative AI Solution from SIIA CODiE
-
BlackLine, Inc. Announces Upsize and Pricing of Offering of $600,000,000 of Convertible Senior Notes
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Man Group PLC : Form 8.3 - Redrow plc
-
Man Group PLC : Form 8.3 - Quanex Building Products Corporation
-
Net Asset Value(s)
-
NIO Inc. to Report Unaudited First Quarter 2024 Financial Results on Thursday, June 6, 2024
-
VEON Receives Nasdaq Notice on Delayed Filing, Confirms Ongoing Effort to Address Auditor Appointment
-
VEON Receives Nasdaq Notice on Delayed Filing, Confirms Ongoing Effort to Address Auditor Appointment
-
Yacht Club de Monaco focuses on the future of the yachting industry

